Foundational Science and Mechanisms of Disease

A 23-year-old woman presents to the outpatient clinic with a 3-day history of swelling and a dull ache in her left calf. Her medical history is unremarkable, and she takes no medications other than an oral contraceptive pill that she started three months ago. Vital signs are within normal limits. Physical examination reveals a 3-cm increase in the circumference of the left calf compared to the right, along with localized tenderness along the deep venous system. A comprehensive metabolic panel and complete blood count are within normal limits. Doppler ultrasound confirms an occlusive thrombus in the left popliteal vein. Family history reveals that her maternal aunt developed a pulmonary embolism at age 30 during her first pregnancy. Which of the following best describes the underlying pathophysiologic mechanism of this patient's most likely condition?

Match the following molecular or genetic lesions with their corresponding classic clinical and laboratory phenotype.

A $54$-year-old man is admitted to the intensive care unit with a severe bloodstream infection caused by *Pseudomonas aeruginosa*. He is to be started on an intravenous aminoglycoside. The patient weighs $80$ kg. His estimated volume of distribution for the drug is $0.25$ L/kg.

To ensure optimal bactericidal activity and minimize the risk of acute tubular necrosis, the clinical pharmacist recommends targeting a steady-state peak serum concentration of $8.0$ mg/L and a steady-state trough serum concentration of $2.0$ mg/L. Based on the patient's current renal function, the elimination half-life of the drug is determined to be $8$ hours.

Assuming the drug follows a one-compartment pharmacokinetic model and distributes instantaneously, what maintenance dose (in mg) must be administered at each dosing interval to achieve these exact steady-state target concentrations?

A 55-year-old woman with a recently diagnosed right-sided breast carcinoma undergoes a lumpectomy followed by adjuvant external beam radiation therapy. The primary therapeutic effect of the ionizing radiation on residual neoplastic cells relies on the generation of reactive oxygen species and the direct induction of double-strand DNA breaks, which ultimately trigger programmed cell death.

Arrange the following subcellular events in the correct chronological order to accurately describe the intrinsic apoptotic cascade that leads to the death of these malignant cells.

Match each patient's clinical presentation and laboratory profile with the most likely underlying coagulation disorder.

A 58-year-old woman is brought to the emergency department via ambulance after experiencing 45 minutes of crushing, substernal chest pain radiating to her left jaw. An electrocardiogram reveals ST-segment elevations in leads V1 through V4. She is rapidly taken to the cardiac catheterization laboratory, where a thrombotic occlusion of the left anterior descending artery is identified. Percutaneous coronary intervention (PCI) is performed, successfully restoring TIMI 3 flow. Over the next several hours, her serum troponin levels peak dramatically higher than expected for the infarct size, and she develops transient arrhythmias. The physician suspects that the restoration of blood flow has paradoxically exacerbated local cellular injury in the border zone of the infarct. Arrange the following subcellular and biochemical events in the correct chronological sequence that mediates this specific type of iatrogenic myocardial damage.

A 47-year-old woman is evaluated in the infectious disease clinic for treatment of a refractory systemic fungal infection following a recent hematopoietic stem cell transplant. She is currently taking tacrolimus and prophylactic acyclovir. The physician plans to start an oral formulation of a novel triazole antifungal agent. The patient's current body weight is $75 \text{ kg}$. According to the pharmacokinetic profile of this new medication, it has an oral bioavailability ($F$) of $50\%$, a volume of distribution ($V_d$) of $2.0 \text{ L/kg}$, and a systemic clearance ($Cl$) of $0.04 \text{ L/hr/kg}$. The therapeutic goal is to maintain an average steady-state plasma concentration ($C_{ss,avg}$) of $15 \text{ mg/L}$. The dosing regimen will consist of administration every 8 hours.

What is the required oral dose in milligrams ($\text{mg}$) to be given every 8 hours to achieve the target steady-state concentration?

A 68-year-old man with a history of hypertension and hyperlipidemia is brought to the emergency department 2 hours after the onset of severe, crushing substernal chest pain. An electrocardiogram reveals prominent ST-segment elevations in leads V1 through V4. He is immediately transferred to the cardiac catheterization laboratory, where a completely occluded proximal left anterior descending artery is identified and successfully opened with a drug-eluting stent. Despite the successful restoration of blood flow and complete resolution of his chest pain, his serum troponin levels exhibit an unexpectedly massive spike four hours post-procedure, accompanied by frequent premature ventricular contractions. Which of the following subcellular processes is the primary mediator of the paradoxical myocardial damage observed following the restoration of perfusion in this patient?

A 42-year-old recent immigrant from Southeast Asia presents to the outpatient clinic with a 6-week history of low-grade fever, drenching night sweats, chronic cough with blood-tinged sputum, and a 5-kg (11-lb) unintentional weight loss. A chest radiograph demonstrates a cavitary lesion in the right upper lobe. Sputum smear is positive for acid-fast bacilli. The patient is initiated on standard quadruple antimicrobial therapy. Several weeks later, the state health department reports that the isolated organism is resistant to the agent within the regimen that primarily inhibits mycolic acid synthesis. Which of the following is the most likely molecular mechanism responsible for this specific drug resistance?

A $58$-year-old man with a history of decompensated alcoholic cirrhosis is recovering from surgical repair of a fractured right femur. During the initial postoperative period, his severe pain was well-controlled with scheduled intravenous morphine. His current laboratory results show a serum albumin of $2.6$ g/dL, total bilirubin of $4.2$ mg/dL, and an International Normalized Ratio (INR) of $1.9$. The medical team is preparing to transition him to an oral morphine regimen for discharge to a skilled nursing facility. Morphine is a classic high hepatic extraction ratio medication ($E_H > 0.7$). Compared to a healthy adult with normal hepatic function, which of the following pharmacokinetic changes is most likely to be observed in this patient upon receiving the oral formulation?

A 4-month-old male infant is brought to the emergency department for poor feeding, a weak cry, and decreased spontaneous movements over the past 2 days. The parents mention that the infant has not had a bowel movement in 4 days and that they recently started giving him a pacifier dipped in raw honey to soothe him. Vital signs show a temperature of 36.8°C (98.2°F), heart rate of 120/min, respiratory rate of 30/min, and blood pressure of 85/50 mmHg. On physical examination, the infant exhibits profound generalized hypotonia, an absent gag reflex, and sluggish pupillary responses. The physician suspects a neuromuscular junction disorder caused by a bacterial neurotoxin.

Arrange the following cellular events in the pathogenesis of this patient's illness in chronological order, from the initial cellular interaction to the ultimate physiologic consequence.

A 19-year-old woman is evaluated in the hematology clinic prior to a scheduled wisdom tooth extraction. She has a history of heavy menstrual bleeding and frequent epistaxis since childhood. Her older brother and mother have similar bleeding tendencies. Laboratory studies show:

Hemoglobin: $11.2 \text{ g/dL}$
Platelet count: $165,000/\text{mm}^3$
Prothrombin time (PT): 11 seconds (Normal: 11-15 s)
Activated partial thromboplastin time (aPTT): 39 seconds (Normal: 25-35 s)
Ristocetin cofactor activity: decreased

A test dose of intravenous desmopressin (DDAVP) is administered to determine if it can be used for hemostatic prophylaxis during her dental procedure. Thirty minutes after the infusion, her platelet count is rechecked and has fallen to $38,000/\text{mm}^3$. Which of the following best describes the underlying molecular pathophysiology of this patient's bleeding disorder?

A 48-year-old woman is brought to the emergency department due to a 3-day history of worsening confusion, generalized fatigue, and fever. Her medical history is unremarkable, and she takes no medications. Her temperature is $38.4^\circ\text{C}$ ($101.1^\circ\text{F}$), blood pressure is $142/85\text{ mm Hg}$, and heart rate is $108/\text{min}$. Physical examination is notable for scleral icterus and scattered petechiae over her lower extremities. Neurological examination reveals mild disorientation but no focal motor or sensory deficits.

Laboratory results are as follows:

A presumptive diagnosis of thrombotic thrombocytopenic purpura (TTP) is made.

Arrange the following diagnostic and management steps in the most appropriate chronological sequence for this patient.

A 62-year-old woman comes to the urgent care clinic complaining of profuse, watery, foul-smelling diarrhea for the past 4 days. She reports having up to 8 bowel movements a day, accompanied by lower abdominal cramping and a low-grade fever. Ten days ago, she was discharged from the hospital after a 5-day admission for community-acquired pneumonia, for which she completed a course of levofloxacin. Her temperature is 38.1°C (100.6°F), pulse is 105/min, and blood pressure is 110/70 mm Hg. Physical examination reveals a mildly distended abdomen with diffuse tenderness but no rebound or guarding. Laboratory studies show a leukocyte count of 18,000/mm³. Stool enzyme immunoassay is positive for a bacterial exotoxin. Which of the following best describes the primary intracellular mechanism of the exotoxin responsible for this patient's gastrointestinal findings?

A 58-year-old man is evaluated in the intensive care unit for high fever, severe hypotension, and progressive respiratory distress. Four days ago, he received an infusion of CD19-directed chimeric antigen receptor (CAR) T cells for refractory diffuse large B-cell lymphoma. His temperature is 39.8°C (103.6°F), blood pressure is 82/50 mm Hg despite receiving 3 L of intravenous crystalloid over the past two hours, pulse is 128/min, and respirations are 28/min. Oxygen saturation is 88% on room air, which improves to 94% on a high-flow nasal cannula. Physical examination reveals warm extremities and bounding pulses. Laboratory studies demonstrate marked elevations in serum ferritin, C-reactive protein, and lactate. Blood cultures are drawn, and empiric broad-spectrum intravenous antibiotics are initiated. Despite these measures and the initiation of a norepinephrine infusion, the patient remains hemodynamically unstable. Which of the following best describes the primary molecular target of the most appropriate specific pharmacotherapy to reverse this patient's acute deterioration?

Distinct stressors and physiologic cues induce specific morphologic changes in human tissues. For each of the following patient presentations, match the clinical scenario with the most accurate description of the underlying cellular adaptation or injury mechanism.

A 34-year-old man who actively injects black tar heroin is brought to the emergency department by his friends due to progressive difficulty opening his mouth, sweating, and severe muscle spasms in his back. He has not received any preventative medical care or vaccinations in over two decades. Physical examination reveals diaphoresis, a fixed facial smile, and pronounced arching of the back. A necrotic, purulent ulcer is noted on his left forearm. The causative pathogen produces a potent neurotoxin responsible for his clinical presentation. Arrange the following steps in the pathophysiological cascade of this toxin's mechanism of action in the correct chronological sequence, from initial host interaction to the ultimate physiologic effect.

A 64-year-old man with a history of heart failure, type 2 diabetes mellitus, and chronic kidney disease stage 5 on hemodialysis is brought to the emergency department by his family due to worsening confusion and unsteadiness over the past two days. His medications include lisinopril, amlodipine, and phenytoin, which he takes for a history of remote post-traumatic seizures. Two weeks ago, a routine chemistry panel showed a blood urea nitrogen of $68 \text{ mg/dL}$, serum creatinine of $5.4 \text{ mg/dL}$, and serum albumin of $2.2 \text{ g/dL}$. At that same visit, his total serum phenytoin level was $6.5 \text{ \mu g/mL}$ (therapeutic range: $10-20 \text{ \mu g/mL}$). Believing the level was subtherapeutic, the physician increased his daily phenytoin dose. Physical examination today reveals bilateral horizontal nystagmus, wide-based gait ataxia, and dysarthria. A repeat total serum phenytoin level today is $13.5 \text{ \mu g/mL}$. Which of the following pharmacokinetic principles best explains why the patient is experiencing neurotoxicity despite a total drug level within the normal therapeutic range?

A 58-year-old man is admitted to the cardiac care unit for the management of recurrent, sustained ventricular tachycardia. An intravenous infusion of lidocaine is initiated at a constant maintenance rate. Forty-eight hours later, the patient develops cardiogenic shock due to an acute myocardial infarction, resulting in severely reduced cardiac output and diminished tissue perfusion. Pharmacokinetic analysis in this low-flow state indicates that both the systemic clearance ($CL$) and the apparent volume of distribution ($V_d$) of lidocaine have decreased by approximately 50%. Assuming the intravenous infusion rate remains constant, which of the following best describes the expected changes in the drug's elimination half-life and steady-state plasma concentration compared to his baseline?

Match each clinical scenario with the most accurate description of its expected primary pharmacokinetic alteration.